Active ingredientMoricizine HydrochlorideCat. No. P-M168-001CAS 29560-58-5Family · Pharmaceutical analytical standards
Moricizine
A class I antiarrhythmic derived from the phenothiazines, developed in the Soviet Union (its synthesis was described in 1972) and approved in the United States in 1990 for serious ventricular arrhythmias; it remained on the market until 2007. This family brings together the active ingredient and other impurities.
Did you know?It was the first Soviet drug approved by the FDA after being licensed to an American company.
Go to the active ingredient →Active ingredientMoricizine HydrochlorideCat. No. P-M168-001CAS 29560-58-5
ImpurityEthacizineCat. No. P-M168-002CAS 33414-33-4
ImpurityMoricizine Impurity 1Cat. No. P-M168-003CAS 34749-22-9
ImpurityEthyl N-(10H-phenothiazin-2-yl)carbamateCat. No. P-M168-004CAS 37711-29-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.